Article
Epirubicin inhibits growth and alters the malignant phenotype of the U‑87 glioma cell line.
Molecular medicine reports - 1 Oct 2015
Wang Xiao-Feng, Zhao Zhe-Feng, Chen Ming-Hui, Yuan Qing-Hua, Li Yong-Li, Jiang Chuan-Lu
Abstract excerpt
Epirubicin, an anthracycline derivative, is one of the main line treatments for brain tumors. The aim of the present study was to verify that epirubicin alters the growth and morphological characteristics of U‑87 glioma cells. In the present study, the effects of epirubicin were tested using cellular and biochemical assays, which demonstrated its anti‑proliferative and cytotoxic effects, with an IC50 of 6.3 µM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
